Skip to content
DataLookout
Menu

BRAVO-LMNCT07789912

BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Phase changed: Phase 2 → Not applicable Show 6 more changesShow less
    • Recruitment opened
    • Eligibility criteria expanded, about 14 words
    • Start date changed from estimate of Oct 1, 2026 to Oct 13, 2026
    • Primary and study completion dates: Oct 1, 2030 to Oct 13, 2030
    • Secondary endpoints: details revised at 8 of 12 entries
    • Site details revised
  2. Minor Secondary endpoints: 7 to 12v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Central Nervous System Progression Free Survival (CNS PFS)
Timeframe: Up to 1.5 years

Secondary (12)

Overall Survival (OS) after brain-avoidant pCSI
Treatment Response Rate After Brain-Avoidant Proton Craniospinal Irradiation (BRAVO-pCSI)
Evaluation of the Safety And Tolerability of Brain-Avoidant Proton Craniospinal Irradiation (BRAVO-pCSI)
Rate of Cognitive Failure After Brain-Avoidant Proton Craniospinal Irradiation (BRAVO-pCSI)
Patient-Reported Depression
Show 7 moreShow less
Patient-Reported Fatigue
Mean Symptom Severity Score (MDASI-BT)
Mean Disease-Specific Symptom Score (MDASI-BT)
Mean Symptom Interference Score (MDASI-BT)
Mean Symptom Severity Score (MDASI-SP)
Mean Disease-Specific Symptom Score (MDASI-SP)
Mean Symptom Interference Score (MDASI-SP)

Arms and interventions

Radiation TreatmentExperimental

Participants in this group will undergo radiation treatments using brain-avoidant proton craniospinal irradiation (CSI). The prescribed radiation dose for all participants will be 30Gy (Cobalt Gray Equivalent \[CGE\]) in 10 fractions.

Non-Interventional ArmNo intervention

Participants who decline BRAVO-pCSI will have the option to enroll in a non-interventional exploratory arm. Participants in this group will undergo the same baseline and follow-up assessments as participants receiving BRAVO-pCSI, including radiographic evaluations, cerebrospinal fluid (CSF) and serum assessments, neurocognitive testing, and quality-of-life assessments. No study intervention will be administered.

Radiation: Radiation Treatments Using Brain- Avoidant Proton Craniospinal Irradiation (BRAVO- pCSI)

Sites

1 site in 1 country

  • University of MiamiMiami, Florida, United States